CVS Corp (CVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,195,000 | 2,795,000 | 1,782,000 | 4,586,000 | 2,963,000 |
| Depreciation Amortization | 9,184,000 | 2,325,000 | 1,154,000 | 4,597,000 | 3,450,000 |
| Income taxes - deferred | -440,000 | -283,000 | -169,000 | -572,000 | -912,000 |
| Accounts receivable | -7,537,000 | -4,139,000 | -3,053,000 | -1,301,000 | -986,000 |
| Accounts payable and accrued liabilities | 5,052,000 | 3,831,000 | 2,619,000 | 2,335,000 | 2,169,000 |
| Other Working Capital | -453,000 | 1,118,000 | 1,427,000 | 109,000 | 503,000 |
| Other Operating Activity | 2,638,000 | 806,000 | 796,000 | -647,000 | 60,000 |
| Operating Cash Flow | $7,249,000 | $6,453,000 | $4,556,000 | $9,107,000 | $7,247,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -18,000 | N/A | N/A |
| PPE Investments | -2,048,000 | -1,350,000 | -743,000 | -2,781,000 | -2,013,000 |
| Net Acquisitions | -429,000 | -139,000 | -20,000 | -95,000 | -85,000 |
| Purchase Of Investment | -11,045,000 | -7,186,000 | N/A | -15,191,000 | -12,677,000 |
| Sale Of Investment | 9,640,000 | 6,866,000 | N/A | 10,353,000 | 7,634,000 |
| Other Investing Activity | 9,000 | 23,000 | 19,000 | 101,000 | 75,000 |
| Investing Cash Flow | $-3,873,000 | $-1,786,000 | $-762,000 | $-7,613,000 | $-7,066,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -872,000 | 921,000 | -859,000 | 1,919,000 | 600,000 |
| Debt Issued | 3,969,000 | 0 | N/A | 7,913,000 | 4,959,000 |
| Debt Repayment | -3,609,000 | -762,000 | -743,000 | -4,773,000 | -1,706,000 |
| Common Stock Issued | 308,000 | 191,000 | 144,000 | 361,000 | 342,000 |
| Common Stock Repurchased | N/A | 0 | 0 | -3,023,000 | -3,023,000 |
| Dividend Paid | -2,552,000 | -1,706,000 | -840,000 | -3,373,000 | -2,535,000 |
| Other Financing Activity | -152,000 | -170,000 | -34,000 | -159,000 | -203,000 |
| Financing Cash Flow | $-2,908,000 | $-1,526,000 | $-2,332,000 | $-1,135,000 | $-1,566,000 |
| Beginning Cash Position | 8,884,000 | 8,884,000 | 8,884,000 | 8,525,000 | 8,525,000 |
| End Cash Position | 9,352,000 | 12,025,000 | 10,346,000 | 8,884,000 | 7,140,000 |
| Net Cash Flow | $468,000 | $3,141,000 | $1,462,000 | $359,000 | $-1,385,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,249,000 | 6,453,000 | 4,556,000 | 9,107,000 | 7,247,000 |
| Capital Expenditure | -2,048,000 | -1,350,000 | -743,000 | -2,781,000 | -2,013,000 |
| Free Cash Flow | 5,201,000 | 5,103,000 | 3,813,000 | 6,326,000 | 5,234,000 |